ACW

ACTINOGEN FPO [ACW]
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Healthcare · ASX Small Cap
$0.0590 -6.4%

Updated 9 Sep 2026 · Signals refresh every scan

Appeared in 4 consecutive scansFirst seen: 2026-03-09
Get alerts when ACW triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track ACW — Free

Active Signals

Bullish Signals

  • MACD momentum is picking up steam
  • Trading above both moving averages — the trend is your friend here
  • Volume surging at 9.8x normal while price falls — heavy selling pressure
  • On a tear — up 22.9% over the last 5 days
  • Beating the Small Ords index — relative strength of 1.32, so it's outpacing the pack
  • Volatility is expanding fast — choppy price action, so buckle up
  • Trading above the 200-day average — the long-term trend is on your side
  • Low cash runway (4 quarters) - dilution risk
  • Strong revenue growth (+97%)
  • Director buying detected (1 transactions)
  • Sentiment is mixed — no strong consensus either way
  • Revenue growing at +97% — the top line is moving in the right direction
  • The bigger volume days are the up days — volume-weighted momentum is positive (3.25%/day)
  • RBA hiking (-3pts)
  • Trial readout: PHASE2 (est. 2026-10)

Risk Signals

  • Stochastic turning bearish from a high level — caution
  • Deeply negative margins (-121%)
  • Not enough chatter to gauge sentiment — defaulting to neutral

Expected next for ACW

30 Oct 2026Quarterly Cash Flow Report (4C)Estimated from past filings
Window: 23 Oct to 6 Nov
The last 5 moved ACW +1.9% on the day, on average — an observation, not a guide to what happens next.
11 Nov 2026Clinical Trial UpdateEstimated from past filings
Window: 12 Oct to 11 Dec
The last 4 moved ACW +5.2% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →

Recent Catalysts

NONE Appendix 3Y-Dr Geoffrey Brooke
NONE Application for quotation of securities - ACW
NONE ACW CMO international Xanamem presentation

Recent ASX Announcements

2026-09-09 Appendix 3Y-Dr Geoffrey Brooke
2026-09-09 Application for quotation of securities - ACW
2026-09-09 ACW CMO international Xanamem presentation
2026-09-08 Application for quotation of securities - ACW
2026-09-07 Application for quotation of securities - ACW

Key Metrics

$229.8M
Market Cap
5.2M
Avg Volume
9.8x
Vol Ratio
$0.03 — $0.07
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-77.5%
ROE
-121.4%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 82%
LLeader vs LaggardpassRS: 38
IInstitutional SponsorshipweakInst: 2%
MMarket DirectionneutralNeutral

Sector: Healthcare

110 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
NUZ +37.1%IPD +20.0%HIQ +16.7%AVE +15.0%CVB +11.1%
Compare:ACW vs NUZACW vs IPDACW vs HIQ
Share this analysis

Track ACW and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required